Skip to Main Content

The trade group for the pharmaceutical industry has filed a lawsuit alleging a pair of Oregon laws is unconstitutional, the latest bid to push back against state efforts to shed more light on the rising cost of prescription medicines.

One law required drug makers to notify the state when list prices rise by at least 10% or a new medicine is introduced that costs more than $670 for a month’s supply. In addition, the drug companies must explain why prices rose and provide detailed information about manufacturing, marketing, and distribution costs. Known as the Disclosure Law, the measure went into effect earlier this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!